Literature DB >> 29627376

Taking adverse outcome pathways to the next level.

Mathieu Vinken1.   

Abstract

Entities:  

Keywords:  adverse outcome pathway; in vitro toxicology

Mesh：

Substances：

Year:  2018        PMID： 29627376      PMCID： PMC6084773          DOI： 10.1016/j.tiv.2018.03.017

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN： 0887-2333            Impact factor:   3.500


× No keyword cloud information.
  14 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

Review 2.  Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies With Different Degrees of Completeness and Scientific Confidence.

Authors:  Edward J Perkins; Philipp Antczak; Lyle Burgoon; Francesco Falciani; Natàlia Garcia-Reyero; Steve Gutsell; Geoff Hodges; Aude Kienzler; Dries Knapen; Mary McBride; Catherine Willett
Journal:  Toxicol Sci       Date:  2015-11       Impact factor: 4.849

3.  Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.

Authors:  Richard A Becker; Gerald T Ankley; Stephen W Edwards; Sean W Kennedy; Igor Linkov; Bette Meek; Magdalini Sachana; Helmut Segner; Bart Van Der Burg; Daniel L Villeneuve; Haruna Watanabe; Tara S Barton-Maclaren
Journal:  Regul Toxicol Pharmacol       Date:  2015-04-08       Impact factor: 3.271

4.  Adverse outcome pathway (AOP) development I: strategies and principles.

Authors:  Daniel L Villeneuve; Doug Crump; Natàlia Garcia-Reyero; Markus Hecker; Thomas H Hutchinson; Carlie A LaLone; Brigitte Landesmann; Teresa Lettieri; Sharon Munn; Malgorzata Nepelska; Mary Ann Ottinger; Lucia Vergauwen; Maurice Whelan
Journal:  Toxicol Sci       Date:  2014-12       Impact factor: 4.849

Review 5.  The adverse outcome pathway concept: A basis for developing regulatory decision-making tools.

Authors:  Nathalie Delrue; Magdalini Sachana; Yuki Sakuratani; Anne Gourmelon; Eeva Leinala; Robert Diderich
Journal:  Altern Lab Anim       Date:  2016-10       Impact factor: 1.303

6.  Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).

Authors:  Knut Erik Tollefsen; Stefan Scholz; Mark T Cronin; Stephen W Edwards; Joop de Knecht; Kevin Crofton; Natalia Garcia-Reyero; Thomas Hartung; Andrew Worth; Grace Patlewicz
Journal:  Regul Toxicol Pharmacol       Date:  2014-09-27       Impact factor: 3.271

Review 7.  Adverse outcome pathways: opportunities, limitations and open questions.

Authors:  Marcel Leist; Ahmed Ghallab; Rabea Graepel; Rosemarie Marchan; Reham Hassan; Susanne Hougaard Bennekou; Alice Limonciel; Mathieu Vinken; Stefan Schildknecht; Tanja Waldmann; Erik Danen; Ben van Ravenzwaay; Hennicke Kamp; Iain Gardner; Patricio Godoy; Frederic Y Bois; Albert Braeuning; Raymond Reif; Franz Oesch; Dirk Drasdo; Stefan Höhme; Michael Schwarz; Thomas Hartung; Thomas Braunbeck; Joost Beltman; Harry Vrieling; Ferran Sanz; Anna Forsby; Domenico Gadaleta; Ciarán Fisher; Jens Kelm; David Fluri; Gerhard Ecker; Barbara Zdrazil; Andrea Terron; Paul Jennings; Bart van der Burg; Steven Dooley; Annemarie H Meijer; Egon Willighagen; Marvin Martens; Chris Evelo; Enrico Mombelli; Olivier Taboureau; Alberto Mantovani; Barry Hardy; Bjorn Koch; Sylvia Escher; Christoph van Thriel; Cristina Cadenas; D Kroese; Bob van de Water; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2017-10-19       Impact factor: 5.153

8.  Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.

Authors:  Sagnik Chatterjee; Lysiane Richert; Patrick Augustijns; Pieter Annaert
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

Review 9.  The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways.

Authors:  Claire L Mellor; Fabian P Steinmetz; Mark T D Cronin
Journal:  Crit Rev Toxicol       Date:  2015-10-09       Impact factor: 5.635

10.  Adverse Outcome Pathways can drive non-animal approaches for safety assessment.

Authors:  Natalie Burden; Fiona Sewell; Melvin E Andersen; Alan Boobis; J Kevin Chipman; Mark T D Cronin; Thomas H Hutchinson; Ian Kimber; Maurice Whelan
Journal:  J Appl Toxicol       Date:  2015-05-05       Impact factor: 3.446
View more
  3 in total

1.  Integration of epidemiological findings with mechanistic evidence in regulatory pesticide risk assessment: EFSA experiences.

Authors:  Olavi Pelkonen; Susanne H Bennekou; Federica Crivellente; Andrea Terron; Antonio F Hernandez
Journal:  Arch Toxicol       Date:  2019-05-03       Impact factor: 5.153

Review 2.  Particle Safety Assessment in Additive Manufacturing: From Exposure Risks to Advanced Toxicology Testing.

Authors:  Andi Alijagic; Magnus Engwall; Eva Särndahl; Helen Karlsson; Alexander Hedbrant; Lena Andersson; Patrik Karlsson; Magnus Dalemo; Nikolai Scherbak; Kim Färnlund; Maria Larsson; Alexander Persson
Journal:  Front Toxicol       Date:  2022-04-25

Review 3.  Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale.

Authors:  Sabina Halappanavar; Sybille van den Brule; Penny Nymark; Laurent Gaté; Carole Seidel; Sarah Valentino; Vadim Zhernovkov; Pernille Høgh Danielsen; Andrea De Vizcaya; Henrik Wolff; Tobias Stöger; Andrey Boyadziev; Sarah Søs Poulsen; Jorid Birkelund Sørli; Ulla Vogel
Journal:  Part Fibre Toxicol       Date:  2020-05-25       Impact factor: 9.400
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.